Rein Therapeutics, Inc. (RNTX)
Data as of , from SEC Form 4 filings.
See up to 3 months of RNTX. The 7-day demo opens the 1M and 3M ranges and puts RNTX on your watchlist.
Start 7-day demoLatest RNTX insider trades
Rickenbach Josef H. vonOpen-market purchase$4K- Rickenbach Josef H. von
About Rein Therapeutics, Inc. (RNTX)
Rein Therapeutics, Inc. files with the SEC under CIK 0001420565 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site. A registration statement was filed on 28 April 2026. No offering has priced.
RNTX Form 4 activity by transaction type, last 90 days
No Form 4 activity for RNTX in the last 90 days.
RNTX insider transactions (Form 4)
2416 Form 4 filings on record, the earliest from Dec 4, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Rickenbach Josef H. von | Open-market purchase | Common stock , $0.001 par value | 3,420 footnote F1 | $1.04 | $4K | |
| Rickenbach Josef H. von | Open-market purchase | Common stock , $0.001 par value | 15,950 footnote F1 | $1.05 | $17K | |
| Rickenbach Josef H. von | Open-market purchase | Common stock , $0.001 par value | 23,190 footnote F1 | $1.06 | $24K | |
| Rickenbach Josef H. von | Open-market purchase | Common stock , $0.001 par value | 4,500 footnote F1 | $1.07 | $5K | |
| ||||||
| James Brian Windsor - Officer | Open-market purchase | Common stock , $0.001 par value | 25,000 footnote F1 | $1.00 | $25K | |
| James Brian Windsor - Officer | Grant or award | Stock Option (Right to Buy) | 150,000 | $0.00 | - | |
| ||||||
| Voss Capital, LP - 10% Owner | Open-market purchase | Common Stock, $0.001 par value | 104,183 | $1.22 footnote F4 | $128K | |
| ||||||
| Voss Capital, LP - 10% Owner | Open-market purchase | Common Stock, $0.001 par value | 178,392 | $1.39 | $248K | |
| Voss Capital, LP - 10% Owner | Open-market purchase | Common Stock, $0.001 par value | 30,176 | $1.39 footnote F4 | $42K | |
| Voss Capital, LP - 10% Owner | Open-market purchase | Common Stock, $0.001 par value | 92,642 | $1.37 | $127K | |
| Voss Capital, LP - 10% Owner | Open-market purchase | Common Stock, $0.001 par value | 4,840 | $1.37 footnote F5 | $7K | |
| ||||||
 Manuel Aivado | Grant or award | Stock Option (right to buy) | 17,500 | $0.00 | - | |
| William Fairey | Grant or award | Stock Option (right to buy) | 17,500 | $0.00 | - | |
 Reinhard J. Ambros | Grant or award | Stock Option (right to buy) | 17,500 | $0.00 | - | |
 Alan A. Musso | Grant or award | Stock Option (right to buy) | 17,500 | $0.00 | - | |
| Rickenbach Josef H. von | Grant or award | Stock Option (right to buy) | 17,500 | $0.00 | - | |
| James Brian Windsor - Officer | Open-market purchase | Common Stock | 239 | $2.24 | $535 | |
| James Brian Windsor - Officer | Open-market purchase | Common Stock | 161 | $2.25 | $362 | |
| William Fairey | Grant or award | Stock Option (right to buy) | 35,000 | $0.00 | - | |
| Manuel Aivado | Grant or award | Stock Option (right to buy) | 35,000 | $0.00 | - | |
| Reinhard J. Ambros | Grant or award | Stock Option (right to buy) | 35,000 | $0.00 | - | |
| Alan A. Musso | Grant or award | Stock Option (right to buy) | 35,000 | $0.00 | - | |
| Rickenbach Josef H. von | Grant or award | Stock Option (right to buy) | 35,000 | $0.00 | - | |
| James Brian Windsor - Officer | Grant or award | Stock Option (right to buy) | 517,500 | $0.00 | - | |
RNTX insider trading FAQ
What is the latest insider trade for RNTX?
Rein Therapeutics, Inc. (RNTX) has filed no insider reports in the last 90 days. The most recent on record is dated 29 May 2026. The full record for RNTX runs to 16 Form 4 filings, the earliest from 4 December 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying RNTX stock?
No insider purchases of RNTX were filed in the last 90 days. 12 purchases are on record for this company.
How many insiders are selling RNTX stock?
No insider sales of RNTX were filed in the last 90 days.
Where can I see RNTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects RNTX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Rickenbach Josef H. von view on EDGAR
- - James Brian Windsor view on EDGAR
- - Voss Capital, LP view on EDGAR
- - Voss Capital, LP view on EDGAR
- - Manuel Aivado view on EDGAR
- - William Fairey view on EDGAR
- - Reinhard J. Ambros view on EDGAR
- - Alan A. Musso view on EDGAR
- - Rickenbach Josef H. von view on EDGAR
- - James Brian Windsor
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where RNTX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow RNTX with a 7-day demo
- RNTX on your watchlist
- Every RNTX Form 4 filing on record
- Up to 3 months of RNTX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
